5439042025-05-025439042025-05-022025-05-02MANKIND PHARMA LIMITEDMANKINDUpdate2025-05-022024-11-152025-01-072025-05-02Creation of Pledge on the shares of Bharat Serums and Vaccines Limited, wholly owned subsidiary of the CompanyOthersThis has reference to our earlier communication dated January 7, 2025 in respect of creation of pledge equal to 95.99% equity shares of Bharat Serums and Vaccines Limited (“BSV”), a wholly owned subsidiary of the Company, in favour of Catalyst Trusteeship Limited as the Common Security Trustee for the benefit of the holders of the listed, rated, secured, redeemable, transferable Non-Convertible Debentures (NCDs), aggregating to INR 5,000 crores issued by the Company in 3 series. We now wish to inform you that, as per terms and conditions of Debenture Trust Deeds, the security cover provided for the aforesaid NCDs was in excess of the mandatory threshold as prescribed under the Debenture Trust Deeds and accordingly, out of the total 95.99% equity shares of BSV pledged as aforesaid, equity shares representing 57.31% have been released today, i.e., May 02, 2025.